Assertio Therapeutics Company Review & Valuation

ASRT
Nasdaq
Latest Price
2.33USD
Market Capitalization
104.00mUSD

About Assertio Therapeutics, Inc.

Assertio Therapeutics, Inc., a specialty pharmaceutical company, engages in the development, sale, and licensing of products for pain and other central nervous system conditions in the United States.

It offers Gralise (gabapentin), an once-daily product for the management of postherpetic neuralgia; CAMBIA (diclofenac potassium for oral solution), a non-steroidal anti-inflammatory drug indicated for acute treatment of migraine attacks in adults; and Zipsor (diclofenac potassium) liquid filled capsule, a non-steroidal anti-inflammatory drug for the treatment of mild to moderate acute pain in adults.

The company also provides NUCYNTA ER (tapentadol extended release tablet), a product for the management of pain severe enough to long term opioid treatment, including neuropathic pain associated with diabetic peripheral neuropathy (DPN) in adults; and NUCYNTA IR (tapentadol), a product for the management of moderate to severe acute pain in adults.

In addition, it is involved in the clinical development of Cebranopadol for the treatment of chronic nociceptive and neuropathic pain.

It has a collaboration and license agreement with Ironwood Pharmaceuticals, Inc.; and a license agreement with Janssen Pharmaceuticals, Inc.

based on its proprietary Acuform gastroretentive drug delivery technology.

The company sells its products to wholesalers and retail pharmacies.

The company was formerly known as Depomed Inc.

and changed its name to Assertio Therapeutics, Inc.

in August 2018 Assertio Therapeutics, Inc.

was founded in 1995 and is headquartered in Lake Forest, Illinois.

Industry
Drug Manufacturers - Specialty & Generic
HQ Location
Lake Forest, Illinois

Stock Price

Price data not available for Assertio Therapeutics.

Performance

Please login or create a free account to view the contents of this section.

Financial Reports

Please login or create a free account to view the contents of this section.

Similar Companies

back to top

Valuu.io

Valuu provides insights and tools for self-directed stock investors. It enables you to easily find, valuate and track your stock investments with the help of reliable financial data and transparent analysis tools.

Disclaimer: This website is a data portal, which aggregates information about public companies. It is not a stock broker and does not give advice concerning specific investment decisions or tax or legal advice. All data is provided "as-is" with no guarantee for correctness and/or completeness. All company names, logos, and brands are intellectual property of their respective owners. The use of them is for editorial purposes only and does not imply any affiliation or endorsement.
© 2019-2022 Valuu Analytics Sàrl